|
Volumn 25, Issue 8, 1998, Pages 1151-1158
|
Early phase II study of S-1 in patients with advanced head and neck cancer. S-1 Cooperative Study Group (Head and Neck Working Group)
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC ANTIMETABOLITE;
OXONIC ACID;
PYRIDINE DERIVATIVE;
S 1 (COMBINATION);
TEGAFUR;
ADULT;
AGED;
ANOREXIA;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
DRUG ADMINISTRATION;
DRUG COMBINATION;
FEMALE;
HEAD AND NECK TUMOR;
HUMAN;
LEUKOPENIA;
LYMPH NODE METASTASIS;
MALE;
METASTASIS;
MIDDLE AGED;
MULTICENTER STUDY;
NEUTROPENIA;
ORAL DRUG ADMINISTRATION;
PATHOLOGY;
PHASE 2 CLINICAL TRIAL;
SQUAMOUS CELL CARCINOMA;
STOMATITIS;
ADMINISTRATION, ORAL;
ADULT;
AGED;
ANOREXIA;
ANTIMETABOLITES, ANTINEOPLASTIC;
CARCINOMA, SQUAMOUS CELL;
DRUG ADMINISTRATION SCHEDULE;
DRUG COMBINATIONS;
FEMALE;
HEAD AND NECK NEOPLASMS;
HUMANS;
LEUKOPENIA;
LYMPHATIC METASTASIS;
MALE;
MIDDLE AGED;
NEUTROPENIA;
OXONIC ACID;
PYRIDINES;
STOMATITIS;
TEGAFUR;
|
EID: 0032109275
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (39)
|
References (0)
|